                               SEQUENCE LISTING

<110> BLAZE BIOSCIENCE, INC.
      FRED HUTCHINSON CANCER RESEARCH CENTER
 
<120> ION CHANNEL-BINDING PEPTIDES AND METHODS OF USE THEREOF

<130> 45639-714.601

<140>
<141>

<150> 62/570,071
<151> 2017-10-09

<160> 88    

<170> PatentIn version 3.5

<210> 1
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Gly Ser Met Cys Met Pro Cys Phe Thr Thr Asp His Gln Met Ala Arg 
1               5                   10                  15      


Arg Cys Asp Asp Cys Cys Gly Gly Arg Gly Arg Gly Arg Cys Tyr Gly 
            20                  25                  30          


Pro Gln Cys Leu Cys Arg 
        35              


<210> 2
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Gly Ser Glu Val Ile Arg Cys Ser Gly Ser Lys Gln Cys Tyr Gly Pro 
1               5                   10                  15      


Cys Lys Gln Gln Thr Gly Cys Thr Asn Ser Lys Cys Met Asn Lys Val 
            20                  25                  30          


Cys Lys Cys Tyr Gly Cys Gly 
        35                  


<210> 3
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Gly Ser Ser Glu Lys Asp Cys Ile Lys His Leu Gln Arg Cys Arg Glu 
1               5                   10                  15      


Asn Lys Asp Cys Cys Ser Lys Lys Cys Ser Arg Arg Gly Thr Asn Pro 
            20                  25                  30          


Glu Lys Arg Cys Arg 
        35          


<210> 4
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 4
Gly Ser Ser Cys Ala Lys Pro Arg Glu Asn Cys Asn Arg Met Asn Ile 
1               5                   10                  15      


Leu Cys Cys Arg Gly Glu Cys Val Cys Pro Thr Phe Gly Asp Cys Phe 
            20                  25                  30          


Cys Tyr Gly Asp 
        35      


<210> 5
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 5
Gly Ser Gly Val Pro Ile Asn Val Lys Cys Arg Gly Ser Arg Asp Cys 
1               5                   10                  15      


Leu Asp Pro Cys Lys Lys Ala Gly Met Arg Phe Gly Lys Cys Ile Asn 
            20                  25                  30          


Ser Lys Cys His Cys Thr Pro 
        35                  


<210> 6
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Gly Ser Val Arg Ile Pro Val Ser Cys Lys His Ser Gly Gln Cys Leu 
1               5                   10                  15      


Lys Pro Cys Lys Asp Ala Gly Met Arg Phe Gly Lys Cys Met Asn Gly 
            20                  25                  30          


Lys Cys Asp Cys Thr Pro Lys 
        35                  


<210> 7
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 7
Gly Ser Asp Cys Val Arg Phe Trp Gly Lys Cys Ser Gln Thr Ser Asp 
1               5                   10                  15      


Cys Cys Pro His Leu Ala Cys Lys Ser Lys Trp Pro Arg Asn Ile Cys 
            20                  25                  30          


Val Trp Asp Gly Ser Val Gly 
        35                  


<210> 8
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 8
Gly Ser Met Cys Met Pro Cys Phe Thr Thr Arg Pro Asp Met Ala Gln 
1               5                   10                  15      


Gln Cys Arg Ala Cys Cys Lys Gly Arg Gly Lys Cys Phe Gly Pro Gln 
            20                  25                  30          


Cys Leu Cys Gly Tyr Asp 
        35              


<210> 9
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 9
Gly Ser Gly Cys Phe Gly Tyr Lys Cys Asp Tyr Tyr Lys Gly Cys Cys 
1               5                   10                  15      


Ser Gly Tyr Val Cys Ser Pro Thr Trp Lys Trp Cys Val Arg Pro Gly 
            20                  25                  30          


Pro Gly Arg 
        35  


<210> 10
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 10
Gly Ser Gln Val Gln Thr Asn Val Lys Cys Gln Gly Gly Ser Cys Ala 
1               5                   10                  15      


Ser Val Cys Arg Arg Glu Ile Gly Val Ala Ala Gly Lys Cys Ile Asn 
            20                  25                  30          


Gly Lys Cys Val Cys Tyr Arg Asn 
        35                  40  


<210> 11
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 11
Gly Ser Gly Asp Cys Leu Pro His Leu Lys Arg Cys Lys Glu Asn Asn 
1               5                   10                  15      


Asp Cys Cys Ser Lys Lys Cys Lys Arg Arg Gly Ala Asn Pro Glu Lys 
            20                  25                  30          


Arg Cys Arg 
        35  


<210> 12
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 12
Gly Ser Asn Phe Lys Val Glu Gly Ala Cys Ser Lys Pro Cys Arg Lys 
1               5                   10                  15      


Tyr Cys Ile Asp Lys Gly Ala Arg Asn Gly Lys Cys Ile Asn Gly Arg 
            20                  25                  30          


Cys His Cys Tyr Tyr 
        35          


<210> 13
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 13
Gly Ser Gln Lys Ile Leu Ser Asn Arg Cys Asn Asn Ser Ser Glu Cys 
1               5                   10                  15      


Ile Pro His Cys Ile Arg Ile Phe Gly Thr Arg Ala Ala Lys Cys Ile 
            20                  25                  30          


Asn Arg Lys Cys Tyr Cys Tyr Pro 
        35                  40  


<210> 14
<211> 44
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 14
Gly Ser Asp Arg Asp Ser Cys Ile Asp Lys Ser Arg Cys Ser Lys Tyr 
1               5                   10                  15      


Gly Tyr Tyr Gln Glu Cys Gln Asp Cys Cys Lys Lys Ala Gly His Asn 
            20                  25                  30          


Gly Gly Thr Cys Met Phe Phe Lys Cys Lys Cys Ala 
        35                  40                  


<210> 15
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 15
Gly Ser Ala Val Cys Asn Leu Lys Arg Cys Gln Leu Ser Cys Arg Ser 
1               5                   10                  15      


Leu Gly Leu Leu Gly Lys Cys Ile Gly Asp Lys Cys Glu Cys Val Lys 
            20                  25                  30          


His Gly 
        


<210> 16
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 16
Gly Ser Gln Phe Cys Gly Thr Asn Gly Lys Pro Cys Val Asn Gly Gln 
1               5                   10                  15      


Cys Cys Gly Ala Leu Arg Cys Val Val Thr Tyr His Tyr Ala Asp Gly 
            20                  25                  30          


Val Cys Leu Lys Met Asn Pro 
        35                  


<210> 17
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 17
Gly Ser Arg Pro Thr Asp Ile Lys Cys Ser Ala Ser Tyr Gln Cys Phe 
1               5                   10                  15      


Pro Val Cys Lys Ser Arg Phe Gly Lys Thr Asn Gly Arg Cys Val Asn 
            20                  25                  30          


Gly Leu Cys Asp Cys Phe 
        35              


<210> 18
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 18
Gly Ser Asn Cys Ala Gly Tyr Met Arg Glu Cys Lys Glu Lys Leu Cys 
1               5                   10                  15      


Cys Ser Gly Tyr Val Cys Ser Ser Arg Trp Lys Trp Cys Val Leu Pro 
            20                  25                  30          


Ala Pro Trp Arg Arg 
        35          


<210> 19
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 19
Gly Ser Gln Phe Thr Asp Val Lys Cys Thr Gly Ser Lys Gln Cys Trp 
1               5                   10                  15      


Pro Val Cys Lys Gln Met Phe Gly Lys Pro Asn Gly Lys Cys Met Asn 
            20                  25                  30          


Gly Lys Cys Arg Cys Tyr Ser 
        35                  


<210> 20
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 20
Gly Ser Gln Ile Asp Thr Asn Val Lys Cys Ser Gly Ser Ser Lys Cys 
1               5                   10                  15      


Val Lys Ile Cys Ile Asp Arg Tyr Asn Thr Arg Gly Ala Lys Cys Ile 
            20                  25                  30          


Asn Gly Arg Cys Thr Cys Tyr Pro 
        35                  40  


<210> 21
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 21
Gly Ser Ala Glu Ile Ile Arg Cys Ser Gly Thr Arg Glu Cys Tyr Ala 
1               5                   10                  15      


Pro Cys Gln Lys Leu Thr Gly Cys Leu Asn Ala Lys Cys Met Asn Lys 
            20                  25                  30          


Ala Cys Lys Cys Tyr Gly Cys Val 
        35                  40  


<210> 22
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 22
Gly Ser Ser Asp Tyr Cys Ser Asn Asp Phe Cys Phe Phe Ser Cys Arg 
1               5                   10                  15      


Arg Asp Arg Cys Ala Arg Gly Asp Cys Glu Asn Gly Lys Cys Val Cys 
            20                  25                  30          


Lys Asn Cys His Leu Asn 
        35              


<210> 23
<211> 41
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 23
Gly Ser Cys Ile Gly Glu Gly Val Pro Cys Asp Glu Asn Asp Pro Arg 
1               5                   10                  15      


Cys Cys Phe Gly Leu Val Cys Leu Lys Pro Thr Leu His Gly Ile Trp 
            20                  25                  30          


Tyr Lys Ser Tyr Tyr Cys Tyr Lys Lys 
        35                  40      


<210> 24
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 24
Gly Ser Ser Cys Ala Lys Pro Gly Glu Met Cys Met Arg Ile Lys Cys 
1               5                   10                  15      


Cys Asp Gly Gln Cys Gly Cys Asn Arg Gly Thr Gly Arg Cys Phe Cys 
            20                  25                  30          


Lys 
    


<210> 25
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 25
Gly Ser Ala Cys Leu Ala Glu Tyr Gln Lys Cys Glu Gly Ser Thr Val 
1               5                   10                  15      


Pro Cys Cys Pro Gly Leu Ser Cys Ser Ala Gly Arg Phe Arg Lys Thr 
            20                  25                  30          


Lys Leu Cys Thr Lys 
        35          


<210> 26
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 26
Gly Ser Val Val Ile Gly Gln Arg Cys Tyr Arg Ser Pro Asp Cys Tyr 
1               5                   10                  15      


Ser Ala Cys Lys Lys Leu Val Gly Lys Ala Thr Gly Lys Cys Thr Asn 
            20                  25                  30          


Gly Arg Cys Asp Cys 
        35          


<210> 27
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 27
Gly Ser Ala Cys Gln Phe Trp Ser Cys Asn Ser Ser Cys Ile Ser Arg 
1               5                   10                  15      


Gly Tyr Arg Gln Gly Tyr Cys Trp Gly Ile Gln Tyr Lys Tyr Cys Gln 
            20                  25                  30          


Cys Gln 
        


<210> 28
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 28
Gly Ser Arg Cys Pro Pro Cys Phe Thr Thr Asn Pro Asn Met Glu Ala 
1               5                   10                  15      


Asp Cys Arg Lys Cys Cys Gly Gly Arg Gly Tyr Cys Ala Ser Tyr Gln 
            20                  25                  30          


Cys Ile Cys Pro Gly Gly 
        35              


<210> 29
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 29
Gly Ser Val Phe Ile Asn Val Lys Cys Arg Gly Ser Pro Glu Cys Leu 
1               5                   10                  15      


Pro Lys Cys Lys Glu Ala Ile Gly Lys Ser Ala Gly Lys Cys Met Asn 
            20                  25                  30          


Gly Lys Cys Lys Cys Tyr Pro 
        35                  


<210> 30
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 30
Gly Ser Gln Val Ser Thr Asn Lys Lys Cys Ser Asn Thr Ser Gln Cys 
1               5                   10                  15      


Tyr Lys Thr Cys Glu Lys Val Val Gly Val Ala Ala Gly Lys Cys Met 
            20                  25                  30          


Asn Gly Lys Cys Ile Cys Tyr Pro 
        35                  40  


<210> 31
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 31
Gly Ser Glu Cys Leu Glu Ile Phe Lys Ala Cys Asn Pro Ser Asn Asp 
1               5                   10                  15      


Gln Cys Cys Lys Ser Ser Lys Leu Val Cys Ser Arg Lys Thr Arg Trp 
            20                  25                  30          


Cys Lys Tyr Gln Ile Gly 
        35              


<210> 32
<211> 56
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 32
Gly Ser Gln Asp Lys Cys Lys Lys Val Tyr Glu Asn Tyr Pro Val Ser 
1               5                   10                  15      


Lys Cys Gln Leu Ala Asn Gln Cys Asn Tyr Asp Cys Lys Leu Asp Lys 
            20                  25                  30          


His Ala Arg Ser Gly Glu Cys Phe Tyr Asp Glu Lys Arg Asn Leu Gln 
        35                  40                  45              


Cys Ile Cys Asp Tyr Cys Glu Tyr 
    50                  55      


<210> 33
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 33
Gly Ser Gly Val Pro Ile Asn Val Arg Cys Arg Gly Ser Arg Asp Cys 
1               5                   10                  15      


Leu Asp Pro Cys Arg Arg Ala Gly Met Arg Phe Gly Arg Cys Ile Asn 
            20                  25                  30          


Ser Arg Cys His Cys Thr Pro 
        35                  


<210> 34
<211> 46
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 34
Gly Gly Tyr Ser Arg Cys Gln Leu Gln Gly Phe Asn Cys Val Val Arg 
1               5                   10                  15      


Ser Tyr Gly Leu Pro Thr Ile Pro Cys Cys Arg Gly Leu Thr Cys Arg 
            20                  25                  30          


Ser Tyr Phe Pro Gly Ser Thr Tyr Gly Arg Cys Gln Arg Tyr 
        35                  40                  45      


<210> 35
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 35
Gly Ser Met Cys Met Pro Cys Phe Thr Thr Asp His Gln Met Ala Arg 
1               5                   10                  15      


Lys Cys Asp Asp Cys Cys Gly Gly Lys Gly Arg Gly Lys Cys Tyr Gly 
            20                  25                  30          


Pro Gln Cys Leu Cys Arg 
        35              


<210> 36
<211> 59
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 36
Gly Ser Ala Gln Glu Pro Val Lys Gly Pro Val Ser Thr Lys Pro Gly 
1               5                   10                  15      


Ser Cys Pro Ile Ile Leu Ile Arg Cys Ala Met Leu Asn Pro Pro Asn 
            20                  25                  30          


Arg Cys Leu Lys Asp Thr Asp Cys Pro Gly Ile Lys Lys Cys Cys Glu 
        35                  40                  45              


Gly Ser Cys Gly Met Ala Cys Phe Val Pro Gln 
    50                  55                  


<210> 37
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 37
Gly Ser Met Cys Met Pro Cys Phe Thr Thr Asp Pro Asn Met Ala Lys 
1               5                   10                  15      


Lys Cys Arg Asp Cys Cys Gly Gly Asn Gly Lys Cys Phe Gly Pro Gln 
            20                  25                  30          


Cys Leu Cys Asn Arg 
        35          


<210> 38
<211> 43
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 38
Gly Ser Gly Ile Gly Asp Pro Val Thr Cys Leu Lys Ser Gly Ala Ile 
1               5                   10                  15      


Cys His Pro Val Phe Cys Pro Arg Arg Tyr Lys Gln Ile Gly Thr Cys 
            20                  25                  30          


Gly Leu Pro Gly Thr Lys Cys Cys Lys Lys Pro 
        35                  40              


<210> 39
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 39
Gly Ser Gly Val Pro Thr Asp Val Lys Cys Arg Gly Ser Pro Gln Cys 
1               5                   10                  15      


Ile Gln Pro Cys Lys Asp Ala Gly Met Arg Phe Gly Lys Cys Met Asn 
            20                  25                  30          


Gly Lys Cys His Cys Thr Pro Lys 
        35                  40  


<210> 40
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 40
Gly Ser Arg Cys Pro Pro Cys Phe Thr Thr Asn Pro Asn Met Glu Ala 
1               5                   10                  15      


Asp Cys Arg Lys Cys Cys Gly Gly Arg Gly Tyr Cys Ala Ser Tyr Gln 
            20                  25                  30          


Cys Ile Cys Pro Gly Gly 
        35              


<210> 41
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 41
Met Cys Met Pro Cys Phe Thr Thr Asp His Gln Met Ala Arg Arg Cys 
1               5                   10                  15      


Asp Asp Cys Cys Gly Gly Arg Gly Arg Gly Arg Cys Tyr Gly Pro Gln 
            20                  25                  30          


Cys Leu Cys Arg 
        35      


<210> 42
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 42
Glu Val Ile Arg Cys Ser Gly Ser Lys Gln Cys Tyr Gly Pro Cys Lys 
1               5                   10                  15      


Gln Gln Thr Gly Cys Thr Asn Ser Lys Cys Met Asn Lys Val Cys Lys 
            20                  25                  30          


Cys Tyr Gly Cys Gly 
        35          


<210> 43
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 43
Ser Glu Lys Asp Cys Ile Lys His Leu Gln Arg Cys Arg Glu Asn Lys 
1               5                   10                  15      


Asp Cys Cys Ser Lys Lys Cys Ser Arg Arg Gly Thr Asn Pro Glu Lys 
            20                  25                  30          


Arg Cys Arg 
        35  


<210> 44
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 44
Ser Cys Ala Lys Pro Arg Glu Asn Cys Asn Arg Met Asn Ile Leu Cys 
1               5                   10                  15      


Cys Arg Gly Glu Cys Val Cys Pro Thr Phe Gly Asp Cys Phe Cys Tyr 
            20                  25                  30          


Gly Asp 
        


<210> 45
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 45
Gly Val Pro Ile Asn Val Lys Cys Arg Gly Ser Arg Asp Cys Leu Asp 
1               5                   10                  15      


Pro Cys Lys Lys Ala Gly Met Arg Phe Gly Lys Cys Ile Asn Ser Lys 
            20                  25                  30          


Cys His Cys Thr Pro 
        35          


<210> 46
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 46
Val Arg Ile Pro Val Ser Cys Lys His Ser Gly Gln Cys Leu Lys Pro 
1               5                   10                  15      


Cys Lys Asp Ala Gly Met Arg Phe Gly Lys Cys Met Asn Gly Lys Cys 
            20                  25                  30          


Asp Cys Thr Pro Lys 
        35          


<210> 47
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 47
Asp Cys Val Arg Phe Trp Gly Lys Cys Ser Gln Thr Ser Asp Cys Cys 
1               5                   10                  15      


Pro His Leu Ala Cys Lys Ser Lys Trp Pro Arg Asn Ile Cys Val Trp 
            20                  25                  30          


Asp Gly Ser Val Gly 
        35          


<210> 48
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 48
Met Cys Met Pro Cys Phe Thr Thr Arg Pro Asp Met Ala Gln Gln Cys 
1               5                   10                  15      


Arg Ala Cys Cys Lys Gly Arg Gly Lys Cys Phe Gly Pro Gln Cys Leu 
            20                  25                  30          


Cys Gly Tyr Asp 
        35      


<210> 49
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 49
Gly Cys Phe Gly Tyr Lys Cys Asp Tyr Tyr Lys Gly Cys Cys Ser Gly 
1               5                   10                  15      


Tyr Val Cys Ser Pro Thr Trp Lys Trp Cys Val Arg Pro Gly Pro Gly 
            20                  25                  30          


Arg 
    


<210> 50
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 50
Gln Val Gln Thr Asn Val Lys Cys Gln Gly Gly Ser Cys Ala Ser Val 
1               5                   10                  15      


Cys Arg Arg Glu Ile Gly Val Ala Ala Gly Lys Cys Ile Asn Gly Lys 
            20                  25                  30          


Cys Val Cys Tyr Arg Asn 
        35              


<210> 51
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 51
Gly Asp Cys Leu Pro His Leu Lys Arg Cys Lys Glu Asn Asn Asp Cys 
1               5                   10                  15      


Cys Ser Lys Lys Cys Lys Arg Arg Gly Ala Asn Pro Glu Lys Arg Cys 
            20                  25                  30          


Arg 
    


<210> 52
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 52
Asn Phe Lys Val Glu Gly Ala Cys Ser Lys Pro Cys Arg Lys Tyr Cys 
1               5                   10                  15      


Ile Asp Lys Gly Ala Arg Asn Gly Lys Cys Ile Asn Gly Arg Cys His 
            20                  25                  30          


Cys Tyr Tyr 
        35  


<210> 53
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 53
Gln Lys Ile Leu Ser Asn Arg Cys Asn Asn Ser Ser Glu Cys Ile Pro 
1               5                   10                  15      


His Cys Ile Arg Ile Phe Gly Thr Arg Ala Ala Lys Cys Ile Asn Arg 
            20                  25                  30          


Lys Cys Tyr Cys Tyr Pro 
        35              


<210> 54
<211> 42
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 54
Asp Arg Asp Ser Cys Ile Asp Lys Ser Arg Cys Ser Lys Tyr Gly Tyr 
1               5                   10                  15      


Tyr Gln Glu Cys Gln Asp Cys Cys Lys Lys Ala Gly His Asn Gly Gly 
            20                  25                  30          


Thr Cys Met Phe Phe Lys Cys Lys Cys Ala 
        35                  40          


<210> 55
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 55
Ala Val Cys Asn Leu Lys Arg Cys Gln Leu Ser Cys Arg Ser Leu Gly 
1               5                   10                  15      


Leu Leu Gly Lys Cys Ile Gly Asp Lys Cys Glu Cys Val Lys His Gly 
            20                  25                  30          


<210> 56
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 56
Gln Phe Cys Gly Thr Asn Gly Lys Pro Cys Val Asn Gly Gln Cys Cys 
1               5                   10                  15      


Gly Ala Leu Arg Cys Val Val Thr Tyr His Tyr Ala Asp Gly Val Cys 
            20                  25                  30          


Leu Lys Met Asn Pro 
        35          


<210> 57
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 57
Arg Pro Thr Asp Ile Lys Cys Ser Ala Ser Tyr Gln Cys Phe Pro Val 
1               5                   10                  15      


Cys Lys Ser Arg Phe Gly Lys Thr Asn Gly Arg Cys Val Asn Gly Leu 
            20                  25                  30          


Cys Asp Cys Phe 
        35      


<210> 58
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 58
Asn Cys Ala Gly Tyr Met Arg Glu Cys Lys Glu Lys Leu Cys Cys Ser 
1               5                   10                  15      


Gly Tyr Val Cys Ser Ser Arg Trp Lys Trp Cys Val Leu Pro Ala Pro 
            20                  25                  30          


Trp Arg Arg 
        35  


<210> 59
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 59
Gln Phe Thr Asp Val Lys Cys Thr Gly Ser Lys Gln Cys Trp Pro Val 
1               5                   10                  15      


Cys Lys Gln Met Phe Gly Lys Pro Asn Gly Lys Cys Met Asn Gly Lys 
            20                  25                  30          


Cys Arg Cys Tyr Ser 
        35          


<210> 60
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 60
Gln Ile Asp Thr Asn Val Lys Cys Ser Gly Ser Ser Lys Cys Val Lys 
1               5                   10                  15      


Ile Cys Ile Asp Arg Tyr Asn Thr Arg Gly Ala Lys Cys Ile Asn Gly 
            20                  25                  30          


Arg Cys Thr Cys Tyr Pro 
        35              


<210> 61
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 61
Ala Glu Ile Ile Arg Cys Ser Gly Thr Arg Glu Cys Tyr Ala Pro Cys 
1               5                   10                  15      


Gln Lys Leu Thr Gly Cys Leu Asn Ala Lys Cys Met Asn Lys Ala Cys 
            20                  25                  30          


Lys Cys Tyr Gly Cys Val 
        35              


<210> 62
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 62
Ser Asp Tyr Cys Ser Asn Asp Phe Cys Phe Phe Ser Cys Arg Arg Asp 
1               5                   10                  15      


Arg Cys Ala Arg Gly Asp Cys Glu Asn Gly Lys Cys Val Cys Lys Asn 
            20                  25                  30          


Cys His Leu Asn 
        35      


<210> 63
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 63
Cys Ile Gly Glu Gly Val Pro Cys Asp Glu Asn Asp Pro Arg Cys Cys 
1               5                   10                  15      


Phe Gly Leu Val Cys Leu Lys Pro Thr Leu His Gly Ile Trp Tyr Lys 
            20                  25                  30          


Ser Tyr Tyr Cys Tyr Lys Lys 
        35                  


<210> 64
<211> 31
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 64
Ser Cys Ala Lys Pro Gly Glu Met Cys Met Arg Ile Lys Cys Cys Asp 
1               5                   10                  15      


Gly Gln Cys Gly Cys Asn Arg Gly Thr Gly Arg Cys Phe Cys Lys 
            20                  25                  30      


<210> 65
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 65
Ala Cys Leu Ala Glu Tyr Gln Lys Cys Glu Gly Ser Thr Val Pro Cys 
1               5                   10                  15      


Cys Pro Gly Leu Ser Cys Ser Ala Gly Arg Phe Arg Lys Thr Lys Leu 
            20                  25                  30          


Cys Thr Lys 
        35  


<210> 66
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 66
Val Val Ile Gly Gln Arg Cys Tyr Arg Ser Pro Asp Cys Tyr Ser Ala 
1               5                   10                  15      


Cys Lys Lys Leu Val Gly Lys Ala Thr Gly Lys Cys Thr Asn Gly Arg 
            20                  25                  30          


Cys Asp Cys 
        35  


<210> 67
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 67
Ala Cys Gln Phe Trp Ser Cys Asn Ser Ser Cys Ile Ser Arg Gly Tyr 
1               5                   10                  15      


Arg Gln Gly Tyr Cys Trp Gly Ile Gln Tyr Lys Tyr Cys Gln Cys Gln 
            20                  25                  30          


<210> 68
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 68
Arg Cys Pro Pro Cys Phe Thr Thr Asn Pro Asn Met Glu Ala Asp Cys 
1               5                   10                  15      


Arg Lys Cys Cys Gly Gly Arg Gly Tyr Cys Ala Ser Tyr Gln Cys Ile 
            20                  25                  30          


Cys Pro Gly Gly 
        35      


<210> 69
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 69
Val Phe Ile Asn Val Lys Cys Arg Gly Ser Pro Glu Cys Leu Pro Lys 
1               5                   10                  15      


Cys Lys Glu Ala Ile Gly Lys Ser Ala Gly Lys Cys Met Asn Gly Lys 
            20                  25                  30          


Cys Lys Cys Tyr Pro 
        35          


<210> 70
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 70
Gln Val Ser Thr Asn Lys Lys Cys Ser Asn Thr Ser Gln Cys Tyr Lys 
1               5                   10                  15      


Thr Cys Glu Lys Val Val Gly Val Ala Ala Gly Lys Cys Met Asn Gly 
            20                  25                  30          


Lys Cys Ile Cys Tyr Pro 
        35              


<210> 71
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 71
Glu Cys Leu Glu Ile Phe Lys Ala Cys Asn Pro Ser Asn Asp Gln Cys 
1               5                   10                  15      


Cys Lys Ser Ser Lys Leu Val Cys Ser Arg Lys Thr Arg Trp Cys Lys 
            20                  25                  30          


Tyr Gln Ile Gly 
        35      


<210> 72
<211> 54
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 72
Gln Asp Lys Cys Lys Lys Val Tyr Glu Asn Tyr Pro Val Ser Lys Cys 
1               5                   10                  15      


Gln Leu Ala Asn Gln Cys Asn Tyr Asp Cys Lys Leu Asp Lys His Ala 
            20                  25                  30          


Arg Ser Gly Glu Cys Phe Tyr Asp Glu Lys Arg Asn Leu Gln Cys Ile 
        35                  40                  45              


Cys Asp Tyr Cys Glu Tyr 
    50                  


<210> 73
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 73
Gly Val Pro Ile Asn Val Arg Cys Arg Gly Ser Arg Asp Cys Leu Asp 
1               5                   10                  15      


Pro Cys Arg Arg Ala Gly Met Arg Phe Gly Arg Cys Ile Asn Ser Arg 
            20                  25                  30          


Cys His Cys Thr Pro 
        35          


<210> 74
<211> 44
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 74
Tyr Ser Arg Cys Gln Leu Gln Gly Phe Asn Cys Val Val Arg Ser Tyr 
1               5                   10                  15      


Gly Leu Pro Thr Ile Pro Cys Cys Arg Gly Leu Thr Cys Arg Ser Tyr 
            20                  25                  30          


Phe Pro Gly Ser Thr Tyr Gly Arg Cys Gln Arg Tyr 
        35                  40                  


<210> 75
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 75
Met Cys Met Pro Cys Phe Thr Thr Asp His Gln Met Ala Arg Lys Cys 
1               5                   10                  15      


Asp Asp Cys Cys Gly Gly Lys Gly Arg Gly Lys Cys Tyr Gly Pro Gln 
            20                  25                  30          


Cys Leu Cys Arg 
        35      


<210> 76
<211> 57
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 76
Ala Gln Glu Pro Val Lys Gly Pro Val Ser Thr Lys Pro Gly Ser Cys 
1               5                   10                  15      


Pro Ile Ile Leu Ile Arg Cys Ala Met Leu Asn Pro Pro Asn Arg Cys 
            20                  25                  30          


Leu Lys Asp Thr Asp Cys Pro Gly Ile Lys Lys Cys Cys Glu Gly Ser 
        35                  40                  45              


Cys Gly Met Ala Cys Phe Val Pro Gln 
    50                  55          


<210> 77
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 77
Met Cys Met Pro Cys Phe Thr Thr Asp Pro Asn Met Ala Lys Lys Cys 
1               5                   10                  15      


Arg Asp Cys Cys Gly Gly Asn Gly Lys Cys Phe Gly Pro Gln Cys Leu 
            20                  25                  30          


Cys Asn Arg 
        35  


<210> 78
<211> 41
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 78
Gly Ile Gly Asp Pro Val Thr Cys Leu Lys Ser Gly Ala Ile Cys His 
1               5                   10                  15      


Pro Val Phe Cys Pro Arg Arg Tyr Lys Gln Ile Gly Thr Cys Gly Leu 
            20                  25                  30          


Pro Gly Thr Lys Cys Cys Lys Lys Pro 
        35                  40      


<210> 79
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 79
Gly Val Pro Thr Asp Val Lys Cys Arg Gly Ser Pro Gln Cys Ile Gln 
1               5                   10                  15      


Pro Cys Lys Asp Ala Gly Met Arg Phe Gly Lys Cys Met Asn Gly Lys 
            20                  25                  30          


Cys His Cys Thr Pro Lys 
        35              


<210> 80
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 80
Arg Cys Pro Pro Cys Phe Thr Thr Asn Pro Asn Met Glu Ala Asp Cys 
1               5                   10                  15      


Arg Lys Cys Cys Gly Gly Arg Gly Tyr Cys Ala Ser Tyr Gln Cys Ile 
            20                  25                  30          


Cys Pro Gly Gly 
        35      


<210> 81
<211> 81
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (2)..(16)
<223> Any amino acid

<220>
<221> MISC_FEATURE
<222> (2)..(16)
<223> This region may encompass 1-15 residues or may be absent in its 
      entirety

<220>
<221> MOD_RES
<222> (18)..(32)
<223> Any amino acid

<220>
<221> MISC_FEATURE
<222> (18)..(32)
<223> This region may encompass 1-15 residues or may be absent in its 
      entirety

<220>
<221> MOD_RES
<222> (34)..(48)
<223> Any amino acid

<220>
<221> MISC_FEATURE
<222> (34)..(48)
<223> This region may encompass 1-15 residues or may be absent in its 
      entirety

<220>
<221> MOD_RES
<222> (50)..(64)
<223> Any amino acid

<220>
<221> MISC_FEATURE
<222> (50)..(64)
<223> This region may encompass 1-15 residues or may be absent in its 
      entirety

<220>
<221> MOD_RES
<222> (66)..(80)
<223> Any amino acid

<220>
<221> MISC_FEATURE
<222> (66)..(80)
<223> This region may encompass 1-15 residues or may be absent in its 
      entirety

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 81
Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35                  40                  45              


Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
    50                  55                  60                  


Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
65                  70                  75                  80  


Cys 
    


<210> 82
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(28)
<223> This sequence may encompass 1-7 "Gly Gly Gly Ser"
      repeating units 

<400> 82
Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   10                  15      


Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
            20                  25              


<210> 83
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(13)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (15)..(17)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (19)..(28)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (30)..(30)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (32)..(33)
<223> Any amino acid or absent


<220>
<221> MOD_RES
<222> (35)..(35)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (37)..(40)
<223> Any amino acid or absent

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 83
Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys Xaa Xaa 
1               5                   10                  15      


Xaa Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys Xaa Asn Xaa 
            20                  25                  30          


Xaa Cys Xaa Cys Xaa Xaa Xaa Xaa 
        35                  40  


<210> 84
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (3)..(5)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (12)..(13)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (20)..(22)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (26)..(26)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (35)..(35)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (37)..(37)
<223> Any amino acid or absent

<220>
<221> MOD_RES
<222> (39)..(40)
<223> Any amino acid or absent

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 84
Xaa Val Xaa Xaa Xaa Val Lys Cys Xaa Gly Ser Xaa Xaa Cys Leu Xaa 
1               5                   10                  15      


Pro Cys Lys Xaa Xaa Xaa Gly Xaa Arg Xaa Gly Lys Cys Met Asn Gly 
            20                  25                  30          


Lys Cys Xaa Cys Xaa Pro Xaa Xaa 
        35                  40  


<210> 85
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 85
Gly Ala Gly Ala 
1               


<210> 86
<211> 37
<212> PRT
<213> Mesobuthus martensii

<400> 86
Val Gly Ile Asn Val Lys Cys Lys His Ser Gly Gln Cys Leu Lys Pro 
1               5                   10                  15      


Cys Lys Asp Ala Gly Met Arg Phe Gly Lys Cys Ile Asn Gly Lys Cys 
            20                  25                  30          


Asp Cys Thr Pro Lys 
        35          


<210> 87
<211> 37
<212> PRT
<213> Mesobuthus martensii

<400> 87
Val Gly Ile Asn Val Lys Cys Lys His Ser Arg Gln Cys Leu Lys Pro 
1               5                   10                  15      


Cys Lys Asp Ala Gly Met Arg Phe Gly Lys Cys Thr Asn Gly Lys Cys 
            20                  25                  30          


His Cys Thr Pro Lys 
        35          


<210> 88
<211> 38
<212> PRT
<213> Leiurus quinquestriatus

<400> 88
Gly Val Pro Ile Asn Val Ser Cys Thr Gly Ser Pro Gln Cys Ile Lys 
1               5                   10                  15      


Pro Cys Lys Asp Ala Gly Met Arg Phe Gly Lys Cys Met Asn Arg Lys 
            20                  25                  30          


Cys His Cys Thr Pro Lys 
        35              


